Bristol-Myers Shares Fall 2.3% Over Last Min. As Traders Circulate Chatter Of Comment From Conference Call Suggesting Exec Said They Will Be Receiving Negative Opinion From CHMP for OPDIVO In Renal Cancer; Conference Call Just Recently Started At 10:30 a.m. EDT
Benzinga Newsdesk